Sandoz's Wyost® and Jubbonti® Gain EC Approval as Biosimilar Versions of Xgeva® and Prolia®

Wyost® (denosumab) and Jubbonti® (denosumab) approved by EC for all indications of denosumab reference medicines Xgeva® and Prolia® EC a...

May 22, 2024 | Wednesday | News
Xcell Biosciences Inc. and AmplifyBio Forge Alliance to Transform Engineered TCR Therapy Manufacturing

Xcell Biosciences Inc. (Xcellbio), an innovative technology company focused on cell and gene therapy manufacturing applications, and AmplifyBio, a rapidly ...

May 20, 2024 | Monday | News
Sartorius Expands Collaboration with NVIDIA to Accelerate Development of Advanced Therapies Through AI Integration

Exploring advanced technologies to help bring novel therapies to patients faster Sartorius to leverage NVIDIA solutions used in live-cell imaging platfo...

May 16, 2024 | Thursday | News
OmniAb, Inc. Showcases Breakthrough in Antibody Discovery at PEGS Boston Summit

OmniAb, Inc. announced its participation in the 20th Annual PEGS Boston – The Essential Protein & Antibody Engineering Summit underway at the Omn...

May 16, 2024 | Thursday | News
German Court Invalidates Patent in NanoString vs. 10x Genomics Case

Bruker Corporation announced that the German Federal Patent Court has ruled in favor of NanoString Technologies Germany GmbH by invalidating European ...

May 08, 2024 | Wednesday | News
QIAGEN and FBI Join Forces to Pioneer Digital PCR Assay for QIAcuity in Forensic Applications

QIAGEN announced a cooperative research and development agreement (CRADA) with the U.S. Federal Bureau of Investigation (FBI) to develop a novel test for i...

May 08, 2024 | Wednesday | News
BBI and BioAgilytix partner to streamline and simplify bioanalytical testing

BBI Solutions OEM Limited (BBI), a trusted expert provider of end-to-end solutions for the development of high-performance assays, has signed a partnership...

May 06, 2024 | Monday | News
Novartis Fortifies RLT Pipeline with Mariana Oncology Acquisition

Transaction reinforces company’s strategic focus on developing next-generation treatment options for patients living with cancer Mariana Oncology ...

May 03, 2024 | Friday | News
Beacon Biosignals & Takeda Forge Partnership to Elevate Sleep Disorder Biomarkers

Beacon Biosignals, the leader in at-home EEG and computational neurodiagnostics, announced a collaboration with Takeda to conduct at-home sleep monitoring ...

May 01, 2024 | Wednesday | News
AbbVie Pledges €150 Million for State-of-the-Art R&D Facility in Germany, Fostering Innovation

New state-of-the-art research and development (R&D) facility at Ludwigshafen to expand discovery and development of new medicines across core therape...

May 01, 2024 | Wednesday | News
MGI Tech Launches Customer Experience Center in Brazil to Drive Genomics Advancement in Latin America

Contributing to the advancement of genomics in Latin America, MGI Tech Co. Ltd. (MGI), a company committed to building core tools and t...

April 29, 2024 | Monday | News
Abzena Introduces EpiScreen® 2.0: Transforms Immunogenicity Assessment for Advanced Therapeutics

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its enhanced bioassay platform EpiScree...

April 29, 2024 | Monday | News
QIAGEN Launches Breakthrough NGS Panel to Bolster Tuberculosis Surveillance and Combat Antimicrobial Resistance

    QIAGEN  announced the launch of the QIAseq xHYB Mycobacterium tuberculosis Panel for research use, a new tool in the fight against t...

April 25, 2024 | Thursday | News
Sandoz celebrates milestone in expanding access to innovative treatments across Europe

Sandoz, a global leader in generic and biosimilar medicines, is pleased to announce the European Commission's (EC) approval of Pyzchiva® (biosimilar us...

April 22, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in